A number of research firms have changed their ratings and price targets for Jazz Pharmaceuticals plc – (NASDAQ: JAZZ): 10/13/2015 – Jazz Pharmaceuticals plc – is now covered by analysts at Northland Securities. They set an “outperform” rating and a $200.00 price target on the stock. 10/12/2015 – Jazz Pharmaceuticals plc – was upgraded by […]
